Company Anatara Lifesciences Ltd

Equities

ANR

AU000000ANR0

Pharmaceuticals

Market Closed - Australian S.E. 02:10:44 2024-04-26 am EDT 5-day change 1st Jan Change
0.048 AUD +4.35% Intraday chart for Anatara Lifesciences Ltd +23.08% +118.18%

Business Summary

Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.

Managers

Managers TitleAgeSince
Chief Executive Officer 63 19-01-22
Chief Operating Officer - -
Corporate Officer/Principal - 21-12-05
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 63 19-01-22
Chief Operating Officer - -
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 167,893,727 107,260,729 ( 63.89 %) 0 63.89 %

Company contact information

Anatara Lifesciences Ltd.

81 Flinders Street C-Perks

5000, Adelaide

+

http://anataralifesciences.com
address Anatara Lifesciences Ltd(ANR)
  1. Stock Market
  2. Equities
  3. ANR Stock
  4. Company Anatara Lifesciences Ltd